pharma QA – Page 98 – Pharma.Tips

Emulsion Inversion after packaging change: complaint trending and risk-based actions

Understanding Emulsion Inversion Following a Packaging Change: A Deep Dive into Investigative Methods In the realm of pharmaceutical manufacturing, emulsion inversion presents a significant challenge, especially after a packaging change.…

Residual Solvent Oos during lamination: GMP investigation plan and CAPA

Investigating Residual Solvent OOS During Lamination: A GMP Approach The occurrence of out-of-specification (OOS) results related to residual solvents during the lamination process can raise significant concerns in pharmaceutical manufacturing…

Fill Volume Variability during method transfer: sampling, filtration, and EM controls

Addressing Variability in Fill Volume during Method Transfer: A Practical Investigation Variability in fill volume during method transfer can lead to significant challenges in pharmaceutical manufacturing, particularly in the production…

Viscosity Drift during shared equipment campaign: GMP investigation and CAPA strategy

Investigation of Viscosity Drift During Shared Equipment Campaigns in Pharmaceutical Manufacturing During shared equipment campaigns in pharmaceutical manufacturing, deviations such as viscosity drift can signal significant risks to product quality…

Adhesion Failure in transdermal patch manufacturing: inspection-ready documentation pack

Investigating Adhesion Failures in Transdermal Patch Production: Comprehensive Documentation Strategies Adhesion failure is a critical concern in the manufacturing of transdermal patches, posing challenges that can lead to quality discrepancies…

Viscosity Drift during method transfer: how to document deviations for FDA/EMA

Understanding and Documenting Viscosity Drift during Method Transfer in Pharmaceutical Manufacturing Viscosity drift during method transfer is a common challenge faced by pharmaceutical manufacturers, particularly in the production of topical…

Curling After Packaging after adhesive change: process parameter review and validation impact

Investigation of Curling Issues Post-Packaging Due to Adhesive Changes The pharmaceutical industry frequently encounters challenges relating to packaging, particularly when alterations to materials occur. One common issue that can arise…

Ccit Failure during sterile filtration: risk assessment for sterility assurance

Ccit Failure during Sterile Filtration: A Comprehensive Investigation Framework CCIT (Container Closure Integrity Testing) failures during sterile filtration processes can create significant risks for sterility assurance, particularly in the pharmaceutical…

Tag: pharma QA

Emulsion Inversion after packaging change: complaint trending and risk-based actions

Residual Solvent Oos during lamination: GMP investigation plan and CAPA

Fill Volume Variability during method transfer: sampling, filtration, and EM controls

Viscosity Drift during shared equipment campaign: GMP investigation and CAPA strategy

Adhesion Failure in transdermal patch manufacturing: inspection-ready documentation pack

Viscosity Drift during method transfer: how to document deviations for FDA/EMA

Curling After Packaging after adhesive change: process parameter review and validation impact

Ccit Failure during sterile filtration: risk assessment for sterility assurance

Edge Lifting during die-cutting: root cause mapping across materials and process

Cleaning Validation Failure during method transfer: cleaning validation and worst-case selection

Edge Lifting at accelerated stability: GMP investigation plan and CAPA

Phase Separation in cream manufacturing: GMP investigation and CAPA strategy